Prelude Therapeutics Incorporated
Utility Patents

Last updated:

List of all Prelude Therapeutics Incorporated patents 8 in total

Status Patent
Grant
Utility: Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) External link
Filling date: 8 Sep 2025 Issue date: 22 Feb 2022
Grant
Utility: Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) External link
Filling date: 8 Sep 2025 Issue date: 11 Jan 2022
Grant
Utility: Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) External link
Filling date: 8 Sep 2025 Issue date: 4 Jan 2022
Grant
Utility: Selective inhibitors of protein arginine methytransterase 5 (PRMT5) External link
Filling date: 8 Sep 2025 Issue date: 28 Dec 2021
Grant
Utility: Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein External link
Filling date: 8 Sep 2025 Issue date: 28 Sep 2021
Grant
Utility: Selective inhibitors of protein arginine methlytransferase 5 (PRMT5) External link
Filling date: 8 Sep 2025 Issue date: 3 Aug 2021
Grant
Utility: Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) External link
Filling date: 8 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) External link
Filling date: 8 Sep 2025 Issue date: 25 Feb 2020

Showing 1 to 8 of 8 patents.